Skip to main content
SpringerLink
Log in

Rituximab linked to fatal infusion-related reactions

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Hoffman-La Roche Limited.RITUXAN (rituximab) and Fatal Infusion Related Reactions in Patients with Rheumatoid Arthritis. Internet Document: [3 pages], 8 Jun 2011. Available from: URL: http://www.hc-sc.gc.ca

  2. Hoffman-La Roche Limited.RITUXAN (rituximab) and Severe and/or Fatal Infusion Related Reactions in Patients with Rheumatoid Arthritis (RA). Internet Document: [2 pages], 8 Jun 2011. Available from: URL: http://www.hc-sc.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rituximab linked to fatal infusion-related reactions. React. Wkly. 1356, 2 (2011). https://doi.org/10.2165/00128415-201113560-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113560-00002

Keywords

Search

Navigation